ArticleOncoimmunology2025

A versatile silica nanoparticle platform for induction of T cell responses - applied for therapeutic vaccination against HPV16 E6/E7-positive tumors in MHC-humanized mice.

Sebastian Kruse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.